Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea · Delayed Price · Currency is KRW 1,912.00
+441.00 (29.98%)
Feb 5, 2026, 3:30 PM KST
Xcell Therapeutics Company Description
Xcell Therapeutics Inc. engages in the development and production of drugs for cell therapy.
It offers CellCor, a serum-free chemically defined medium that is used to develop human mesenchymal stem cells.
The company also offers XPorT, a platform that aims to develop optimal media from the perspective of the user using a variety of cells.
In addition, it develops media for cell culture in various areas of the bioindustry such as cell therapy, gene therapy, exosomes, organoids and bioreactors.
Xcell Therapeutics Inc. was founded in 2015 and is based in Seoul, South Korea.
Xcell Therapeutics Inc.
| Country | South Korea |
| Founded | 2015 |
| Industry | Biotechnology |
| Sector | Healthcare |
Contact Details
Address: Dongwon Building Seoul South Korea | |
| Phone | 82 2 863 1331 |
| Website | xcell.co.kr |
Stock Details
| Ticker Symbol | 373110 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7373110006 |
| SIC Code | 2836 |